pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
155
stories
Sep 29, 26
Canadian $5M accelerated clinical trial program cuts start-up to 45 days
fiercebiotech
Sep 25, 26
After COVID, biomanufacturing tackles preparedness and commercialization challenges
biospace
Sep 23, 26
China’s surging biotech sector represents both competition and lifeline for the US
biospace
Sep 21, 26
Pentagon defends designating WuXi AppTec as Chinese military company
endpoints
Sep 21, 26
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
biospace
Sep 17, 26
Webinar: Manufacturing in Turbulent Times
biospace
Sep 17, 26
DPHARM: How to address the clinical trial enrollment crisis?
fiercebiotech
Sep 17, 26
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
Sep 15, 26
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
biospace
Sep 15, 26
FDA launches pilot program to speed up early US drug research
biopharma dive
Sep 15, 26
FDA launches pilot program to speed up sluggish phase 1 trials
fiercebiotech
Sep 14, 26
Cyclic peptides open new drug frontiers, if manufacturing can keep up
biospace
Sep 14, 26
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
Sep 11, 26
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
fiercebiotech
Sep 11, 26
Samsung Biologics inks $262M manufacturing deal with European pharma company
biospace
Sep 10, 26
Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'
fiercebiotech
Sep 10, 26
Lonza to build new US factory; Samsung Bio signs $262M contract
endpoints
Sep 10, 26
The supply chain fault lines of modern pharma
biospace
Sep 10, 26
August biopharma layoffs impact just over 500, down 90% year over year
biospace
Sep 9, 26
nPhase launches AI clinical data management platform to soup up sponsor trial design
fiercebiotech
Sep 8, 26
4 CDMOs to consider when outsourcing manufacturing
biospace
Sep 4, 26
Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets
endpoints
Sep 3, 26
The hidden scale-out problem behind CAR-T’s growth
biopharma dive
Sep 2, 26
Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
fiercebiotech
Aug 28, 26
Multispecifics are transforming the CDMO development architecture
biospace
Aug 28, 26
CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own
biospace
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 27, 26
RayzeBio's $173M radiopharma plan; Lonza creates commercial chief position
endpoints
Aug 26, 26
BMS ends Cellares pact over cell therapy production problems, triggering layoffs
biospace
Aug 26, 26
Beyond the Bandwidth Ceiling: Redesigning Advanced Therapy Operating Models for the Digital Staff Era
fiercebiotech
← prev
page 3 of 6
next →